ECO Animal Health Group plc

LSE EAH.L

ECO Animal Health Group plc Price to Earnings Ratio (P/E) on January 14, 2025: 41.27

ECO Animal Health Group plc Price to Earnings Ratio (P/E) is 41.27 on January 14, 2025, a -47.77% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

ECO Animal Health Group plc 52-week high Price to Earnings Ratio (P/E) is 89.25 on June 06, 2024, which is 116.22% above the current Price to Earnings Ratio (P/E).
ECO Animal Health Group plc 52-week low Price to Earnings Ratio (P/E) is 36.38 on December 20, 2024, which is -11.85% below the current Price to Earnings Ratio (P/E).
ECO Animal Health Group plc average Price to Earnings Ratio (P/E) for the last 52 weeks is 66.73.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

LSE: EAH.L

ECO Animal Health Group plc

CEO	Mr. David Charles Hallas
IPO Date	Sept. 26, 1995
Location	United Kingdom
Headquarters	78 Coombe Road
Employees	227
Sector	Health Care
Industries Pharmaceuticals Biotechnology Pet Food

Description

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Key trends

Past 5 years